E C Kingsley - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Filters

E C Kingsley

Showing results (1-10 of 4) with videos related to

Pageof 1

Sort By:

Scandinavian Journal of Haematology|August 1, 1986

Prolonged survival in patients with treatment-related leukemiaE C Kingsley, B G Durie

The Western Journal of Medicine|March 1, 1987

Acute promyelocytic leukemiaE C Kingsley, B G Durie, H S Garewal

Cancer Genetics and Cytogenetics|November 1, 1989

Trisomy 14: a new entity within acute nonlymphocytic leukemiaA Meloni-Balliet, R Morgan, J L Poth, et al.

ESMO Open|April 1, 2026

Comparative efficacy of zanubrutinib plus obinutuzumab versus last prior treatment in relapsed/refractory follicular lymphoma: growth modulation index analysis from the ROSEWOOD studyJ Trotman, K Bouabdallah, F Bijou, et al.

Pageof 1

Search research articles

Showing results (1-10 of 4) with videos related to

Sort By:

Pageof 1

Scandinavian Journal of Haematology|August 1, 1986

Prolonged survival in patients with treatment-related leukemiaE C Kingsley, B G Durie

The Western Journal of Medicine|March 1, 1987

Acute promyelocytic leukemiaE C Kingsley, B G Durie, H S Garewal

Cancer Genetics and Cytogenetics|November 1, 1989

Trisomy 14: a new entity within acute nonlymphocytic leukemiaA Meloni-Balliet, R Morgan, J L Poth, et al.

ESMO Open|April 1, 2026

Comparative efficacy of zanubrutinib plus obinutuzumab versus last prior treatment in relapsed/refractory follicular lymphoma: growth modulation index analysis from the ROSEWOOD studyJ Trotman, K Bouabdallah, F Bijou, et al.

Pageof 1